机译:妊娠期间与选择性5-羟色胺再摄取抑制剂的使用相关的先天性心脏病
CHRISTINA L. WICHMAN, DO, KATHERINE M. MOORE, MD, TARA R. LANG, MD, JENNIFER L. ST. SAUVER, PHD, ROBERT H. HEISE JR, MD, AND WILLIAM J. WATSON, MDFrom the Department of Psychiatry and Psychology (C.L.W., K.M.M.), Division of Epidemiology (J.L.S.), and Department of Obstetrics and Gynecology (R.H.H., W.J.W.), Mayo Clinic, Rochester, MN, and Department of Neonatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH (T.R.L).Presented in part at the 160th Annual Meeting of the American Psychiatric Association, May 21, 2007, San Diego, CA.Individual reprints of this article are not available. Address correspondence to Christina L. Wichman, DO, Department of Psychiatry and Psychology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (wichman.christina @mayo.edu).© 2009 Mayo Foundation for Medical Education and Research,;
机译:与妊娠期间选择性使用5-羟色胺再摄取抑制剂有关的先天性心脏病。
机译:选择性5-羟色胺再摄取抑制剂和先天性心脏异常:妊娠前后妇女及其子女的比较队列研究
机译:选择性5-羟色胺再摄取抑制剂与先天性心脏异常:妊娠前后妇女及其子女的比较队列研究
机译:选择性血清素再摄取抑制剂(SSRI)与血清素转运蛋白相互作用的分子机制
机译:孕妇在怀孕期间使用选择性5-羟色胺再摄取抑制剂与不良妊娠结局之间的关联。
机译:妊娠期间与选择性5-羟色胺再摄取抑制剂的使用相关的先天性心脏病
机译:妊娠期间与选择性5-羟色胺再摄取抑制剂的使用相关的先天性心脏病